Seul-Ki Lee
Net worth: 175 M $ as of 29/09/2026
Net worth: 175 M $ as of 29/09/2026
Dr. Seul-Ki Lee is a Chief Executive Officer & Director at Neuraly, Inc. and a CEO, Director, Head-Research & Technology at D&D Pharmatech Co., Ltd. He is on the Board of Directors at Neuraly, Inc. and D&D Pharmatech Co., Ltd. Dr. Lee was previously employed as a Chief Executive Officer by Theraly Fibrosis, Inc.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
D&D PHARMATECH CO., LTD. 12.34% | 29/06/2026 | 5,655,524 ( 12.34% ) | 175 M $ | 29/09/2026 |
| Companies | Position | Start |
|---|---|---|
| D&D PHARMATECH INC. | Chief Executive Officer | - |
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Founder | 31/12/2015 |
| Companies | Position | End |
|---|---|---|
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Chief Executive Officer | 31/12/2023 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 3 |
|---|---|
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Commercial Services |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
D&D Pharma Tech Co., Ltd.
D&D Pharma Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions